Kontour Historical Cash Flow
| 688314 Stock | 28.89 0.89 3.18% |
Analysis of Kontour Medical cash flow over time is an excellent tool to project Kontour Medical Tech future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Free Cash Flow of 49.7 M or Begin Period Cash Flow of 198 M as it is a great indicator of Kontour Medical ability to facilitate future growth, repay debt on time or pay out dividends.
Kontour |
About Kontour Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Kontour balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Kontour's non-liquid assets can be easily converted into cash.
Kontour Medical Cash Flow Chart
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Dividends Paid
The total amount of dividends that a company has paid out to its shareholders over a specific period.Capital Expenditures
Capital Expenditures are funds used by Kontour Medical Tech to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Kontour Medical operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from Kontour Medical's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Kontour Medical Tech current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Kontour Medical Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At present, Kontour Medical's Capital Expenditures is projected to increase significantly based on the last few years of reporting. The current year's Total Cash From Operating Activities is expected to grow to about 87.1 M, whereas Change To Inventory is forecasted to decline to (5.5 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Other Non Cash Items | 2.2M | 3.9M | 5.0M | 2.8M | Depreciation | 10.6M | 11.8M | 12.3M | 10.4M |
Kontour Medical cash flow statement Correlations
Click cells to compare fundamentals
Kontour Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Currently Active Assets on Macroaxis
Other Information on Investing in Kontour Stock
The Cash Flow Statement is a financial statement that shows how changes in Kontour balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Kontour's non-liquid assets can be easily converted into cash.